Sector: Pharmaceuticals & Biotechnology

Large Cap

Neuland Laboratories Share Price

Neuland Laboratories Ltd.

₹16,779

86.00(0.52%)

Invest in NEULANDLAB with up to 2.22x margin.

Trade with MTF

25th May 2026 | 2:41 PM

NSE : NEULANDLAB

Open Free Demat Account

Neuland Laboratories Performance

Price Movement

₹16779.00

₹16650.00

₹17000.00

↘ Today's Low↗ Today's High

1 Year Performance

₹16779.00

₹11011.00

₹19747.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹17,000.00

Low₹16,650.00

Open at₹16,785.00

Prev Close₹16,693.00

Volumes20.91 K

Avg Price₹16,790.08

Lower Circuit₹13,355.00

Upper Circuit₹20,031.00

Historical Performance

3M High₹18,305.00

3M Low₹11,500.00

1 Yr High₹19,747.00

1 Yr Low₹11,011.00

3 Yr High₹19,747.00

3 Yr Low₹2,603.60

5 Yr High₹19,747.00

5 Yr Low₹967.00

Neuland Laboratories Fundamentals

Market Cap

High in industry

21,328.40 Cr.

PE Ratio (TTM)

High in industry

58.60

Dividend Yield

Low in industry

0.10

Net Profit TTM

39.9% incr over last year

364

Net Profit Growth

39.9% incr over last year

364

PEG Ratio

High in industry

1.50

ROE

13.8% incr over last year

19.41

Operating Revenue TTM

2,022.99

Operating Revenue Growth

37.0% incr over last year

Book Value

High in industry

12.80

MFI

MFI is mid-range

47.40

RSI

RSI is mid-range

62.10

EPS (TTM)

283.71

Debt to Equity

0.10

Face Value

Operating Profit Margin Qtr.

27.98

Operating Profit Qtr.

307.33

Net Profit Qtr.

212.67

Operating Revenue Qtr.

776.25

PB Ratio

12.80

Neuland Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	776.25	439.71	514.27	292.75	328.36
Operating Expense	469.35	362.78	359.15	258.46	277.61
Operating Profit	306.90	76.93	155.12	34.29	50.75
Depreciation	25.09	23.92	22.54	20.19	16.89
Interest	7.23	6.79	5.34	4.58	2.35
Tax	74.52	13.86	32.58	3.67	11.25
Net Profit	212.52	40.42	96.46	13.71	27.73

Neuland Laboratories Technicals

Neuland Laboratories Ltd. EMA & SMA

₹16779.00

-11.00 (-0.07%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹16663.1

Day EMA10 ₹16566.7

Day EMA12 ₹16479.2

Day EMA20 ₹16057.4

Day EMA26 ₹15755

Day EMA50 ₹14995.2

Day EMA100 ₹14594.1

Day EMA200 ₹14295.9

Neuland Laboratories Support and Resistance

Resistance

First Resistance₹17022.67

Second Resistance₹17255.33

Third Resistance₹17644.67

Support

First Support₹16400.67

Second Support₹16011.33

Third Support₹15778.67

Technical Indicators

Day RSI62.10

Day MFI47.40

Day ADX33.63

Day Commodity Channel Index41.20

William-39.44

Day MACD724.30

Day MACD Signal Line793.18

Day ATR727.31

Day ROC125-2.51

Day ROC219.77

Neuland Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	32.7	32.7	32.7	32.6	32.6	32.6
FII	23.9	22.1	21.7	20.6	20.9	20.5
DII	9.5	11.4	12	14	14.7	15.8
Public	34	33.8	33.7	32.8	31.8	31.1

Neuland Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	27.3 K	56.5 K	48.33%
Week	52.49 K	1.57 L	33.51%
1 Month	31.68 K	86.96 K	36.43%
6 Month	18.79 K	59.44 K	31.61%

Neuland Laboratories SWOT Analysis

Strengths24

Weakness10

Opportunity4

Threats0

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Strong QoQ EPS Growth in recent results

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Neuland Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Jul, 2025	12	FINAL	18 Jul, 2025	Equity Share
12 Jul, 2024	14	FINAL		Equity Share
11 Jul, 2023	10	FINAL		Equity Share
14 Jul, 2022	5	FINAL	15 Jul, 2022	Equity Share
29 Jun, 2021	3	FINAL		Equity Share
10 Nov, 2020	2	INTERIM	11 Nov, 2020	Equity Share
18 Feb, 2020	2	INTERIM	20 Feb, 2020	Equity Share
27 Jun, 2019	1.2	FINAL		Equity Share
04 Aug, 2016	2	FINAL		Equity Share
06 Aug, 2015	1.5	FINAL		Equity Share

Neuland Laboratories Stock Comparison

Financials	Anthem Biosciences Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹769.50	₹1,173.90	₹1,795.50	₹1,737.60	₹2,455.40	₹179.27
% Change	-0.98%	5.40%	-2.13%	1.40%	-0.97%	2.07%
Revenue TTM (₹ Cr)	₹2,124.33	₹2,192.49	₹1,421.59	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹591.79	₹348.91	₹-73.80	₹924.36	₹1,912.93	₹-325.93
PE TTM	74.10	69.40	-290.10	35.60	55.80	-71.90
1 Year Return	36.93	52.37	14.63	61.15	0.77	-14.16
ROCE	27.56	18.38	0.59	25.65	13.27	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2920.60

-1.04%

GLAND

Gland Pharma Ltd.

₹ 2344.60

+0.45%

LAURUSLABS

Laurus Labs Ltd.

₹ 1354.80

+0.84%

ALKEM

Alkem Laboratories Ltd.

₹ 5390.50

-0.26%

BIOCON

Biocon Ltd.

₹ 429.50

-0.17%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6755.00

-1.92%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3095.20

-0.40%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1073.45

+3.32%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2344.00

+3.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1631.00

+3.53%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1457.90

-0.38%

NATCOPHARM

Natco Pharma Ltd.

₹ 1170.40

+0.06%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1838.00

-0.36%

IPCALAB

Ipca Laboratories Ltd.

₹ 1574.40

-1.73%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2238.00

+2.07%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8863.50

+3.21%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2306.00

-0.04%

PFIZER

Pfizer Ltd.

₹ 4705.00

+0.73%

ABBOTINDIA

Abbott India Ltd.

₹ 27705.00

-0.45%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4602.50

+2.59%

LUPIN

Lupin Ltd.

₹ 2287.40

+0.25%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1333.40

+2.00%

CIPLA

Cipla Ltd.

₹ 1419.10

+1.42%

FAQ's on NEULANDLAB

What is the current share price of Neuland Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Neuland Laboratories Ltd. is ₹ 16779 on the NSE and ₹ 16800 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Neuland Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Neuland Laboratories Ltd. is approximately ₹ 21328.4 Cr.

What are the PE and PB ratios for Neuland Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Neuland Laboratories Ltd. is 58.6, and the Price-to-Book (PB) ratio is 12.8.

What is the 52-Week High and Low for Neuland Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Neuland Laboratories Ltd. shares was ₹ 19747, and the lowest price was ₹ 11011.

What is the current dividend yield for Neuland Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Neuland Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Neuland Laboratories Ltd.?

Significant shareholdings in Neuland Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Neuland Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Neuland Laboratories Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Neuland Laboratories Ltd.?

Neuland Laboratories Ltd. last declared a FINAL dividend of ₹ 12 per share for the financial period ending 2025. The record date was set as 2025-07-18, and the payment was/is scheduled around 2025-07-18. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy